Report cover image

Axillary Hyperhidrosis Treatment Market

Publisher Future Market Insights
Published Apr 18, 2023
Length 247 Pages
SKU # FMARI19383644

Description

Axillary Hyperhidrosis Treatment Market


Axillary Hyperhidrosis Treatment Market: Global Industry Analysis 2017-2022 and Opportunity Assessment 2023-2033

A recent market study published by FMI on Axillary Hyperhidrosis Treatment offers a global industry analysis for 2017-2022 and opportunity assessment for 2023-2033. The study offers a comprehensive assessment of the most important market dynamics. After conducting thorough research on the historical and current growth parameters, the growth prospects of the market are obtained with maximum precision.

Market Segmentation

By Treatment:
  • Drug Therapy
  • Antiperspirants (Both OTC & Rx)
  • Antiperspirants Spray

  • Antiperspirants Roll-On

  • Antiperspirants Wipes

  • Antiperspirants Lotion & Gel
    • Antihypertensive Drugs
    • Anticholinergic Agents
    • Alpha-Adrenergic Agonists
    • Botulinum Toxins
    • Medicated Wipes
    • Microwave Therapy
    By Distribution Channel:
    • Hospitals
    • General Physician’s Clinics
    • Retail Pharmacy Chains
    • Drug Stores
    • Online Sales
    • Manufacturer websites
    By Region:
    • North America
    • Latin America
    • Europe
    • South Asia
    • East Asia
    • Oceania
    • Middle East and Africa (MEA)
    Report Chapters

    Executive Summary

    The executive summary of the Axillary Hyperhidrosis Treatment Market includes the global market outlook, demand side trends, supply side trends and also include FMI analysis and recommendations of Vehicle Radar Test System.

    Chapter 01 - Market Overview

    Readers can find the detailed segmentation and definition of the Axillary Hyperhidrosis Treatment Market in this chapter, which will help to understand basic information about Vehicle Radar Test System. This section also highlights the market scope, taxonomy and limitations which help the reader understand the market coverage of Axillary Hyperhidrosis Treatment Market report.

    Chapter 02 - Market Background

    This chapter includes detailed analysis of the By Treatment processing methods overview, consumer buying patterns & tendencies and policy developments and regulatory scenario. It also includes in depth analysis of macro-economic factors and covers topics like global GDP growth outlook, global industry value added, personal consumption, expenditures, modern trade penetration and consumer price indices. The chapter also covers forecast factors - relevance & impact, value chain analysis and market dynamics (drivers, restraints and opportunities) to better understand the market.

    Chapter 03 - Global Axillary Hyperhidrosis Treatment Market Demand Analysis 2017-2022 and Forecast, 2023-2033

    The chapter include historical market value (US$ 1.6 Billion) analysis (2017-2022) and current and future market value (US$ 1.8 Billion) and volume (6.7%) projections (2023-2033). The projections are based on the Y-O-Y growth trend analysis and absolute $ opportunity analysis country of operation.

    Chapter 04 - Global Axillary Hyperhidrosis Treatment Market - Pricing Analysis

    Based on By Treatment, the pricing analysis chapter include Regional pricing analysis (USD/MT), global average pricing analysis benchmark, and key factors impacting the pricing.

    Chapter 05 - Global Axillary Hyperhidrosis Treatment Market Analysis 2017-2022 and Forecast 2023-2033, By Treatment

    Based on By Treatment, Axillary Hyperhidrosis Treatment Market is segmented into Drug Therapy (Antiperspirants, Antihypertensive Drugs, Anticholinergic Agents, Alpha-Adrenergic Agonists), Botulinum Toxins, Medicated Wipes, Microwave Therapy. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By Treatment.

    Chapter 06 - Global Axillary Hyperhidrosis Treatment Market Analysis 2017-2022 and Forecast 2023-2033, By Distribution Channel

    Based on By Distribution Channel, Axillary Hyperhidrosis Treatment Market is segmented into Hospitals, General Physician’s Clinics, Retail Pharmacy Chains, Drug Stores (Online Sales, Manufacturer websites). This section also offers market attractiveness analysis based on By Distribution Channel. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By Distribution Channel.

    Chapter 07 - Axillary Hyperhidrosis Treatment Market Analysis 2017-2022 and Forecast 2023-2033, By Region

    Based on By Region, Axillary Hyperhidrosis Treatment Market is segmented into North America, Latin America, Europe, South Asia, East Asia, Oceania, Middle East and Africa (MEA). This section also offers market attractiveness analysis based on By Region. Readers can also find value forecast and Y-o-Y growth comparison for all above mentioned By Region.

    Chapter 08 - North America Axillary Hyperhidrosis Treatment Market Analysis 2017-2022 and Forecast 2023-2033

    This chapter includes a detailed analysis of the growth of the Vehicle Radar Test System in the North American region, along with a country-wise assessment that includes the US and Canada. Readers can also find regional trends, regulations, and market growth based on different segment and countries in the North America region.

    Chapter 09 - Latin America Axillary Hyperhidrosis Treatment Market Analysis 2017-2022 and Forecast 2023-2033

    This chapter includes a detailed analysis of the growth of Vehicle Radar Test System in the Latin America region, along with a country-wise assessment that includes the Brazil, Mexico, Chile, Argentina, Peru and Rest of Latin America. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Axillary Hyperhidrosis Treatment Market in the Latin America region.

    Chapter 10 - Europe Axillary Hyperhidrosis Treatment Market Analysis 2017-2022 and Forecast 2023-2033

    This chapter includes a detailed analysis of the growth of Vehicle Radar Test System in the European region, along with a country-wise assessment that includes the Germany, Italy, France, U.K., Spain, Russia, Nordic, Benelux and Rest of Europe. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Axillary Hyperhidrosis Treatment Market in the regional market.

    Chapter 11 - East Asia Axillary Hyperhidrosis Treatment Market Analysis 2017-2022 and Forecast 2023-2033

    This chapter includes a detailed analysis of the growth of Vehicle Radar Test System in the East Asia region, along with a country-wise assessment that includes the China, Japan, and South Korea. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Axillary Hyperhidrosis Treatment Market in the regional market.

    Chapter 12 - South Asia Axillary Hyperhidrosis Treatment Market Analysis 2017-2022 and Forecast 2023-2033

    This chapter includes a detailed analysis of the growth of Vehicle Radar Test System in the South Asia region, along with a country-wise assessment that includes the India, Indonesia, Malaysia, Thailand, and Rest of South Asia. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Axillary Hyperhidrosis Treatment Market in the regional market.

    Chapter 13 - Middle East and Africa Axillary Hyperhidrosis Treatment Market Analysis 2017-2022 and Forecast 2023-2033

    This chapter includes a detailed analysis of the growth of Vehicle Radar Test System in the MEA region, along with a country-wise assessment that includes the GCC Countries, South Africa, North Africa, Turkey and Rest of MEA. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Axillary Hyperhidrosis Treatment Market in the regional market.

    Chapter 14 - Key Countries Axillary Hyperhidrosis Treatment Market Analysis 2017-2022 and Forecast 2023-2033

    This chapter offers insights into how the Axillary Hyperhidrosis Treatment Market is expected to grow in major countries globally.

    Chapter 15 - Market Structure Analysis- Global Assessment

    This chapter includes company dashboard, industry structure analysis by tier of companies, 2022E, company share analysis of top players, 2022E, and competition benchmarking- matrix.

    Chapter 16 - Competition Deep Dive (Tentative List)

    This chapter includes company overview, By Treatment portfolio of companies, profitability by market segments, sales footprint, SWOT analysis and strategy overview of the companies being studied in the report. Some of the market players featured in the report are Allergan plc. (AbbVie), Journey Medical Corporation (Dermira, Inc.), Riemann A/S (Orkla), SweatBlock, Certain Dri, miraDry, Inc. (Sientra), STRATUS PHARMACEUTICALS INC, Duradry, Persn & Covey, GlaxoSmithKline Plc., Carpe, SweatStop® International, CORAD Healthcare, ZeroSweat.

    Chapter 17 - Assumptions and Acronyms

    This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the Vehicle Radar Test System report.

    Chapter 18 - Research Methodology

    This chapter helps readers understand the research methodology followed to obtain various conclusions, as well as important qualitative and quantitative information, on Axillary Hyperhidrosis Treatment Market.

    Table of Contents

    247 Pages
    1. Executive Summary | Axillary Hyperhidrosis Treatment Market
    1.1. Global Market Outlook
    1.2. Demand Side Trends
    1.3. Supply-Side Side Trends
    1.4. Analysis and Recommendations
    2. Market Overview
    2.1. Market Coverage / Taxonomy
    2.2. Market Definition / Scope / Limitations
    2.3. Inclusions and Exclusions
    3. Key Market Trends
    3.1. Key Trends Impacting the Market
    3.2. Innovation / Development Trends
    4. Value Added Insights
    4.1. Disease Epidemiology
    4.2. Patent Analysis
    4.3. Pipeline Assessment
    4.4. Value Chain Analysis
    4.5. Regulatory Scenario
    4.6. PESTLE Analysis
    4.7. Porter’s Analysis
    5. Market Background
    5.1. Macro-Economic Factors
    5.1.1. Global GDP Growth Outlook
    5.1.2. Global Healthcare Spending Outlook
    5.1.3. Global Dermatology Therapeutics Market Overview
    5.2. Forecast Factors - Relevance & Impact
    5.2.1. Increasing Prevalence of Axillary Hyperhidrosis
    5.2.2. Treatment Seeking Rate (%)
    5.2.3. Adoption of Various Treatment Modalities
    5.2.4. Greater Demand for Non-Invasive Procedures
    5.2.5. Increasing Initiatives by Manufacturers to Educate the General Population
    5.2.6. Products in Pipeline
    5.2.7. Availability of Products
    5.3. Market Dynamics
    5.3.1. Drivers
    5.3.2. Restraints
    5.3.3. Opportunity Analysis
    6. COVID-19 Crisis Analysis
    6.1. COVID-19 and Impact Analysis
    6.1.1. By Treatment
    6.1.2. By Distribution Channel
    6.1.3. By Country
    6.2. 2022 Market Scenario
    7. Global Market Demand (in Value or Size in US$ Million) Analysis 2017 to 2022 and Forecast, 2023 to 2033
    7.1. Historical Market Value (US$ Million) Analysis 2017 to 2022
    7.2. Current and Future Market Value (US$ Million) Projections, 2023 to 2033
    7.2.1. Y-o-Y Growth Trend Analysis
    7.2.2. Absolute $ Opportunity Analysis
    8. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Treatment
    8.1. Introduction / Key Findings
    8.2. Historical Market Size (US$ Million) Analysis By Treatment, 2017 to 2022
    8.3. Current and Future Market Size (US$ Million) Analysis and Forecast, By Treatment, 2023 to 2033
    8.3.1. Drug Therapy
    8.3.1.1. Antiperspirants (Both OTC & Rx)
    8.3.1.1.1. Antiperspirants Spray
    8.3.1.1.2. Antiperspirants Roll-On
    8.3.1.1.3. Antiperspirants Wipes
    8.3.1.1.4. Antiperspirants Lotion & Gel
    8.3.1.2. Antihypertensive Drugs
    8.3.1.3. Anticholinergic Agents
    8.3.1.4. Alpha-Adrenergic Agonists
    8.3.2. Botulinum Toxins
    8.3.3. Medicated Wipes
    8.3.4. Microwave Therapy
    8.4. Market Attractiveness Analysis By Treatment
    9. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Distribution Channel
    9.1. Introduction
    9.2. Historical Market Size (US$ Million) Analysis By Distribution Channel, 2017 to 2022
    9.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Distribution Channel, 2023 to 2033
    9.3.1. Hospitals
    9.3.2. General Physician’s Clinics
    9.3.3. Retail Pharmacy Chains
    9.3.4. Drug Stores
    9.3.4.1. Online Sales
    9.3.4.2. Manufacturer websites
    9.4. Market Attractiveness Analysis By Distribution Channel
    10. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region
    10.1. Introduction
    10.2. Historical Market Value (US$ Million) Analysis By Region, 2017 to 2022
    10.3. Current and Future Market Size (US$ Million) Analysis and Forecast, By Region, 2023 to 2033
    10.3.1. North America
    10.3.2. Latin America
    10.3.3. Europe
    10.3.4. South Asia
    10.3.5. East Asia
    10.3.6. Oceania
    10.3.7. Middle East & Africa
    10.4. Market Attractiveness Analysis By Region
    11. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033
    11.1. Introduction
    11.2. Historical Market Value (US$ Million) Analysis, By Market Taxonomy 2017 to 2022
    11.3. Current and Future Market Size (US$ Million) Analysis and Forecast, By Market Taxonomy, 2023 to 2033
    11.3.1. By Country
    11.3.1.1. USA
    11.3.1.2. Canada
    11.3.2. By Treatment
    11.3.3. By Distribution Channel
    11.4. Market Attractiveness Analysis
    11.4.1. By Country
    11.4.2. By Treatment
    11.4.3. By Distribution Channel
    11.5. Market Trends
    11.6. Key Market Participants - Intensity Mapping
    11.7. Drivers and Restraints - Impact Analysis
    11.8. Country Level Analysis & Forecast
    11.8.1. USA Market
    11.8.1.1. Introduction
    11.8.1.2. Market Analysis and Forecast by Market Taxonomy
    11.8.1.2.1. By Treatment
    11.8.1.2.2. By Distribution Channel
    11.8.2. Canada Market
    11.8.3. Introduction
    11.8.4. Market Analysis and Forecast by Market Taxonomy
    11.8.4.1.1. By Treatment
    11.8.4.1.2. By Distribution Channel
    12. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033
    12.1. Introduction
    12.2. Historical Market Value (US$ Million) Analysis, By Market Taxonomy 2017 to 2022
    12.3. Current and Future Market Size (US$ Million) Analysis and Forecast, By Market Taxonomy, 2023 to 2033
    12.3.1. By Country
    12.3.1.1. Brazil
    12.3.1.2. Mexico
    12.3.1.3. Argentina
    12.3.1.4. Rest of Latin America
    12.3.2. By Treatment
    12.3.3. By Distribution Channel
    12.4. Market Attractiveness Analysis
    12.4.1. By Country
    12.4.2. By Treatment
    12.4.3. By Distribution Channel
    12.5. Market Trends
    12.6. Key Market Participants - Intensity Mapping
    12.7. Drivers and Restraints - Impact Analysis
    12.8. Country Level Analysis & Forecast
    12.8.1. Brazil Market
    12.8.1.1. Introduction
    12.8.1.2. Market Analysis and Forecast by Market Taxonomy
    12.8.1.2.1. By Treatment
    12.8.1.2.2. By Distribution Channel
    12.8.2. Mexico Market
    12.8.2.1. Introduction
    12.8.2.2. Market Analysis and Forecast by Market Taxonomy
    12.8.2.2.1. By Treatment
    12.8.2.2.2. By Distribution Channel
    12.8.3. Argentina Market
    12.8.4. Introduction
    12.8.5. Market Analysis and Forecast by Market Taxonomy
    12.8.5.1.1. By Treatment
    12.8.5.1.2. By Distribution Channel
    13. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033
    13.1. Introduction
    13.2. Historical Market Value (US$ Million) Analysis, By Market Taxonomy 2017 to 2022
    13.3. Current and Future Market Size (US$ Million) Analysis and Forecast, By Market Taxonomy, 2023 to 2033
    13.3.1. By Country
    13.3.1.1. Germany
    13.3.1.2. Italy
    13.3.1.3. France
    13.3.1.4. United kingdom
    13.3.1.5. Spain
    13.3.1.6. BENELUX
    13.3.1.7. Russia
    13.3.1.8. Nordic Countries
    13.3.1.9. Rest of Europe
    13.3.2. By Treatment
    13.3.3. By Distribution Channel
    13.4. Market Attractiveness Analysis
    13.4.1. By Country
    13.4.2. By Treatment
    13.4.3. By Distribution Channel
    13.5. Market Trends
    13.6. Key Market Participants - Intensity Mapping
    13.7. Drivers and Restraints - Impact Analysis
    13.8. Country Level Analysis & Forecast
    13.8.1. Germany Market
    13.8.1.1. Introduction
    13.8.1.2. Market Analysis and Forecast by Market Taxonomy
    13.8.1.2.1. By Treatment
    13.8.1.2.2. By Distribution Channel
    13.8.2. Italy Market
    13.8.2.1. Introduction
    13.8.2.2. Market Analysis and Forecast by Market Taxonomy
    13.8.2.2.1. By Treatment
    13.8.2.2.2. By Distribution Channel
    13.8.3. France Market
    13.8.3.1. Introduction
    13.8.3.2. Market Analysis and Forecast by Market Taxonomy
    13.8.3.2.1. By Treatment
    13.8.3.2.2. By Distribution Channel
    13.8.4. United kingdom Market
    13.8.4.1. Introduction
    13.8.4.2. Market Analysis and Forecast by Market Taxonomy
    13.8.4.2.1. By Treatment
    13.8.4.2.2. By Distribution Channel
    13.8.5. Spain Market
    13.8.5.1. Introduction
    13.8.5.2. Market Analysis and Forecast by Market Taxonomy
    13.8.5.2.1. By Treatment
    13.8.5.2.2. By Distribution Channel
    13.8.6. BENELUX Market
    13.8.6.1. Introduction
    13.8.6.2. Market Analysis and Forecast by Market Taxonomy
    13.8.6.2.1. By Treatment
    13.8.6.2.2. By Distribution Channel
    13.8.7. Russia Market
    13.8.7.1. Introduction
    13.8.7.2. Market Analysis and Forecast by Market Taxonomy
    13.8.7.2.1. By Treatment
    13.8.7.2.2. By Distribution Channel
    13.8.8. Nordic Countries Market
    13.8.8.1. Introduction
    13.8.8.2. Market Analysis and Forecast by Market Taxonomy
    13.8.8.2.1. By Treatment
    13.8.8.2.2. By Distribution Channel
    14. East Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033
    14.1. Introduction
    14.2. Historical Market Value (US$ Million) Analysis, By Market Taxonomy 2017 to 2022
    14.3. Current and Future Market Size (US$ Million) Analysis and Forecast, By Market Taxonomy, 2023 to 2033
    14.3.1. By Country
    14.3.1.1. China
    14.3.1.2. Japan
    14.3.1.3. South Korea
    14.3.2. By Treatment
    14.3.3. By Distribution Channel
    14.4. Market Attractiveness Analysis
    14.4.1. By Country
    14.4.2. By Treatment
    14.4.3. By Distribution Channel
    14.5. Market Trends
    14.6. Key Market Participants - Intensity Mapping
    14.7. Drivers and Restraints - Impact Analysis
    14.8. Country Level Analysis & Forecast
    14.8.1. China Market
    14.8.1.1. Introduction
    14.8.1.2. Market Analysis and Forecast by Market Taxonomy
    14.8.1.2.1. By Treatment
    14.8.1.2.2. By Distribution Channel
    14.8.2. Japan Market
    14.8.2.1. Introduction
    14.8.2.2. Market Analysis and Forecast by Market Taxonomy
    14.8.2.2.1. By Treatment
    14.8.2.2.2. By Distribution Channel
    14.8.3. South Korea Market
    14.8.3.1. Introduction
    14.8.3.2. Market Analysis and Forecast by Market Taxonomy
    14.8.3.2.1. By Treatment
    14.8.3.2.2. By Distribution Channel
    15. South Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033
    15.1. Introduction
    15.2. Historical Market Value (US$ Million) Analysis, By Market Taxonomy 2017 to 2022
    15.3. Current and Future Market Size (US$ Million) Analysis and Forecast, By Market Taxonomy, 2023 to 2033
    15.3.1. By Country
    15.3.1.1. India
    15.3.1.2. Indonesia
    15.3.1.3. Malaysia
    15.3.1.4. Thailand
    15.3.1.5. Rest of South Asia
    15.3.2. By Treatment
    15.3.3. By Distribution Channel
    15.4. Market Attractiveness Analysis
    15.4.1. By Country
    15.4.2. By Treatment
    15.4.3. By Distribution Channel
    15.5. Market Trends
    15.6. Key Market Participants - Intensity Mapping
    15.7. Drivers and Restraints - Impact Analysis
    15.8. Country Level Analysis & Forecast
    15.8.1. India Market
    15.8.1.1. Introduction
    15.8.1.2. Market Analysis and Forecast by Market Taxonomy
    15.8.1.2.1. By Treatment
    15.8.1.2.2. By Distribution Channel
    15.8.2. Indonesia Market
    15.8.2.1. Introduction
    15.8.2.2. Market Analysis and Forecast by Market Taxonomy
    15.8.2.2.1. By Treatment
    15.8.2.2.2. By Distribution Channel
    15.8.3. Malaysia Treatment Market
    15.8.3.1. Introduction
    15.8.3.2. Market Analysis and Forecast by Market Taxonomy
    15.8.3.2.1. By Treatment
    15.8.3.2.2. By Distribution Channel
    15.8.4. Thailand Market
    15.8.4.1. Introduction
    15.8.4.2. Market Analysis and Forecast by Market Taxonomy
    15.8.4.2.1. By Treatment
    15.8.4.2.2. By Distribution Channel
    16. Oceania Market Analysis 2017 to 2022 and Forecast 2023 to 2033
    16.1. Introduction
    16.2. Historical Market Value (US$ Million) Analysis, By Market Taxonomy 2017 to 2022
    16.3. Current and Future Market Size (US$ Million) Analysis and Forecast, By Market Taxonomy, 2023 to 2033
    16.3.1. By Country
    16.3.1.1. Australia
    16.3.1.2. New Zealand
    16.3.2. By Treatment
    16.3.3. By Distribution Channel
    16.4. Market Attractiveness Analysis
    16.4.1. By Country
    16.4.2. By Treatment
    16.4.3. By Distribution Channel
    16.5. Market Trends
    16.6. Key Market Participants - Intensity Mapping
    16.7. Drivers and Restraints - Impact Analysis
    16.8. Country Level Analysis & Forecast
    16.8.1. Australia Treatment Market
    16.8.1.1. Introduction
    16.8.1.2. Market Analysis and Forecast by Market Taxonomy
    16.8.1.2.1. By Treatment
    16.8.1.2.2. By Distribution Channel
    16.8.2. New Zealand Treatment Market
    16.8.2.1. Introduction
    16.8.2.2. Market Analysis and Forecast by Market Taxonomy
    16.8.2.2.1. By Treatment
    16.8.2.2.2. By Distribution Channel
    17. Middle East and Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033
    17.1. Introduction
    17.2. Historical Market Value (US$ Million) Analysis, By Market Taxonomy 2017 to 2022
    17.3. Current and Future Market Size (US$ Million) Analysis and Forecast, By Market Taxonomy, 2023 to 2033
    17.3.1. By Country
    17.3.1.1. GCC Countries
    17.3.1.2. Türkiye
    17.3.1.3. South Africa
    17.3.1.4. North Africa
    17.3.1.5. Rest of Middle East and Africa
    17.3.2. By Treatment
    17.3.3. By Distribution Channel
    17.4. Market Attractiveness Analysis
    17.4.1. By Country
    17.4.2. By Treatment
    17.4.3. By Distribution Channel
    17.5. Market Trends
    17.6. Key Market Participants - Intensity Mapping
    17.7. Drivers and Restraints - Impact Analysis
    17.8. Country Level Analysis & Forecast
    17.8.1. GCC Countries Market
    17.8.1.1. Introduction
    17.8.1.2. Market Analysis and Forecast by Market Taxonomy
    17.8.1.2.1. By Treatment
    17.8.1.2.2. By Distribution Channel
    17.8.2. Türkiye Market
    17.8.2.1. Introduction
    17.8.2.2. Market Analysis and Forecast by Market Taxonomy
    17.8.2.2.1. By Treatment
    17.8.2.2.2. By Distribution Channel
    17.8.3. South Africa Market
    17.8.3.1. Introduction
    17.8.3.2. Market Analysis and Forecast by Market Taxonomy
    17.8.3.2.1. By Treatment
    17.8.3.2.2. By Distribution Channel
    17.8.4. North Africa Market
    17.8.4.1. Introduction
    17.8.4.2. Market Analysis and Forecast by Market Taxonomy
    17.8.4.2.1. By Treatment
    17.8.4.2.2. By Distribution Channel
    18. Market Structure Analysis
    18.1. Market Analysis by Tier of Companies
    18.2. Market Share Analysis (%) of Top Players
    18.3. Market Presence Analysis
    18.3.1. Regional Footprint of Players
    18.3.2. Channel Foot Print by Players
    19. Competition Analysis
    19.1. Competition Dashboard
    19.2. Competition Benchmarking
    19.3. Promotional and Branding Strategies by Manufacturers
    19.4. Competition Deep Dive
    19.4.1. Allergan plc. (AbbVie)
    19.4.1.1. Overview
    19.4.1.2. Treatment Portfolio
    19.4.1.3. Sales Footprint
    19.4.1.4. Key Financials
    19.4.1.5. SWOT Analysis
    19.4.1.6. Strategy Overview
    19.4.2. Journey Medical Corporation (Dermira, Inc.)
    19.4.2.1. Overview
    19.4.2.2. Treatment Portfolio
    19.4.2.3. Sales Footprint
    19.4.2.4. Key Financials
    19.4.2.5. SWOT Analysis
    19.4.2.6. Strategy Overview
    19.4.3. Riemann A/S (Orkla)
    19.4.3.1. Overview
    19.4.3.2. Treatment Portfolio
    19.4.3.3. Sales Footprint
    19.4.3.4. Key Financials
    19.4.3.5. SWOT Analysis
    19.4.3.6. Strategy Overview
    19.4.4. SweatBlock
    19.4.4.1. Overview
    19.4.4.2. Treatment Portfolio
    19.4.4.3. Sales Footprint
    19.4.4.4. Key Financials
    19.4.4.5. SWOT Analysis
    19.4.4.6. Strategy Overview
    19.4.5. Certain Dri
    19.4.5.1. Overview
    19.4.5.2. Treatment Portfolio
    19.4.5.3. Sales Footprint
    19.4.5.4. Key Financials
    19.4.5.5. SWOT Analysis
    19.4.5.6. Strategy Overview
    19.4.6. miraDry, Inc. (Sientra)
    19.4.6.1. Overview
    19.4.6.2. Treatment Portfolio
    19.4.6.3. Sales Footprint
    19.4.6.4. Key Financials
    19.4.6.5. SWOT Analysis
    19.4.6.6. Strategy Overview
    19.4.7. STRATUS PHARMACEUTICALS INC
    19.4.7.1. Overview
    19.4.7.2. Treatment Portfolio
    19.4.7.3. Sales Footprint
    19.4.7.4. Key Financials
    19.4.7.5. SWOT Analysis
    19.4.7.6. Strategy Overview
    19.4.8. Duradry
    19.4.8.1. Overview
    19.4.8.2. Treatment Portfolio
    19.4.8.3. Sales Footprint
    19.4.8.4. Key Financials
    19.4.8.5. SWOT Analysis
    19.4.8.6. Strategy Overview
    19.4.9. Persōn & Covey
    19.4.9.1. Overview
    19.4.9.2. Treatment Portfolio
    19.4.9.3. Sales Footprint
    19.4.9.4. Key Financials
    19.4.9.5. SWOT Analysis
    19.4.9.6. Strategy Overview
    19.4.10. GlaxoSmithKline Plc.
    19.4.10.1. Overview
    19.4.10.2. Treatment Portfolio
    19.4.10.3. Sales Footprint
    19.4.10.4. Key Financials
    19.4.10.5. SWOT Analysis
    19.4.10.6. Strategy Overview
    19.4.11. Carpe
    19.4.11.1. Overview
    19.4.11.2. Treatment Portfolio
    19.4.11.3. Sales Footprint
    19.4.11.4. Key Financials
    19.4.11.5. SWOT Analysis
    19.4.11.6. Strategy Overview
    19.4.12. SweatStop® International
    19.4.12.1. Overview
    19.4.12.2. Treatment Portfolio
    19.4.12.3. Sales Footprint
    19.4.12.4. Key Financials
    19.4.12.5. SWOT Analysis
    19.4.12.6. Strategy Overview
    19.4.13. CORAD Healthcare
    19.4.13.1. Overview
    19.4.13.2. Treatment Portfolio
    19.4.13.3. Sales Footprint
    19.4.13.4. Key Financials
    19.4.13.5. SWOT Analysis
    19.4.13.6. Strategy Overview
    19.4.14. ZeroSweat
    19.4.14.1. Overview
    19.4.14.2. Treatment Portfolio
    19.4.14.3. Sales Footprint
    19.4.14.4. Key Financials
    19.4.14.5. SWOT Analysis
    19.4.14.6. Strategy Overview
    20. Assumptions and Acronyms Used
    21. Research Methodology

    Pricing

    Currency Rates
    How Do Licenses Work?

    How Do Licenses Work?

    The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

    • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

    • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

    • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

    • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

    • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

    License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

    Head shot

    Questions or Comments?

    Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
    Chat Now
    Contact Us